Back

Real world experience of efficacy and safety using proprotein convertase subtilisin / Kexin 9 (PCSK9) inhibition in patients with Familial Hypercholesterolemia

8 April 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session III - Saturday 08:30 - 12:30 - Diabetes/ Lipids/Obesity/Nutrition_Part 1 Lipids EAPC Premium Access EuroPrevent 2017

About the speaker

Photo
Doctor Annette Galema-Boers

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

14 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Presentation thumbnail
Associate Professor N. Burko (Penza, RU)
Abstract
Presentation thumbnail
Professor D. Panagiotakos (Athens, GR)
Abstract
Presentation thumbnail

Access the full session

Session thumbnail
Poster Session III - Saturday 08:30 - 12:30 - Diabetes/ Lipids/Obesity/Nutrition_Part 1

The Event

Event poster

EuroPrevent 2017

8 April 2017 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources